808: The PI3K/mTOR inhibitor NVP-BEZ235 is able to revert selumetinib resistance in colorectal cancer cellular models

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 50; p. S195
Main Authors Martinez-Lacaci, I, Carballo-Santana, M, Tristante, E, Mayor-López, L, Grasso, S, Carbonell, P, De Torre, C, Luján, J, Alonso, J.L, Carballo, F
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.07.2014
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

Author Luján, J
Alonso, J.L
Grasso, S
Carballo-Santana, M
Martinez-Lacaci, I
Tristante, E
Carbonell, P
Mayor-López, L
De Torre, C
Carballo, F
Author_xml – sequence: 1
  fullname: Martinez-Lacaci, I
– sequence: 2
  fullname: Carballo-Santana, M
– sequence: 3
  fullname: Tristante, E
– sequence: 4
  fullname: Mayor-López, L
– sequence: 5
  fullname: Grasso, S
– sequence: 6
  fullname: Carbonell, P
– sequence: 7
  fullname: De Torre, C
– sequence: 8
  fullname: Luján, J
– sequence: 9
  fullname: Alonso, J.L
– sequence: 10
  fullname: Carballo, F
BookMark eNqFkE1LxDAURYMoOH78BCFLXVSTtmlSF4oOfqE4oqMLNyFJXzGaaSTpDPjvTWfEhRtXjzxyD--eLbTe-Q4Q2qPkkBJaHT2RmtWZIGW9T8sDRjgtMr6GRlTwOiOC5eto9PtlE23F-E4I4aIkIzQXRBzj6Rvgh5vi9mg2nTxi271ZbXsf8P3LQ3Z-8ZoXDNuIlXaAe48DLCD0OIKbz6C3ndVpFW3sVWcgpbHxzgcwvXLYDLuADTg3dyrgmW_AxR200SoXYfdnbqPny4vp-Dq7m1zdjM_uMkMZ55muaWsACqNbYlhtykJQCiVUmtG8KSothGCNSO9KKU5A1JXWFatyUbQtTxq2EVtxTfAxBmjlZ7AzFb4kJXJwJ5fu5CBG0lIu3UmecqerXLoVFhaCjMZCatLYoZdsvP2XcPKHYFwyZZT7gC-I734eutRcUhlzSVaQgUHLJYEX3-FSjGA
ContentType Journal Article
Copyright European Association for Cancer Research
2014 European Association for Cancer Research
Copyright_xml – notice: European Association for Cancer Research
– notice: 2014 European Association for Cancer Research
DBID AAYXX
CITATION
DOI 10.1016/S0959-8049(14)50713-7
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-0852
EndPage S195
ExternalDocumentID 10_1016_S0959_8049_14_50713_7
S0959804914507137
1_s2_0_S0959804914507137
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29G
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAWTL
AAXKI
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABUDA
ABXDB
ACDAQ
ACIUM
ACPRK
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFKWA
AFRAH
AFRHN
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HED
HMK
HMO
HVGLF
HZ~
IHE
J1W
K-O
KOM
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UV1
WUQ
X7M
XPP
Z5R
ZGI
ZXP
~G-
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
DOVZS
EFLBG
LCYCR
ZA5
AAYXX
CITATION
ID FETCH-LOGICAL-c1577-b91fcee3cbf0c59c43811e4e6b512d36b8885d8e6b6aa70e896bb656283ff7713
IEDL.DBID AIKHN
ISSN 0959-8049
IngestDate Thu Sep 26 16:24:47 EDT 2024
Fri Feb 23 02:20:31 EST 2024
Tue Oct 15 23:02:39 EDT 2024
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1577-b91fcee3cbf0c59c43811e4e6b512d36b8885d8e6b6aa70e896bb656283ff7713
ParticipantIDs crossref_primary_10_1016_S0959_8049_14_50713_7
elsevier_sciencedirect_doi_10_1016_S0959_8049_14_50713_7
elsevier_clinicalkeyesjournals_1_s2_0_S0959804914507137
PublicationCentury 2000
PublicationDate July 2014
PublicationDateYYYYMMDD 2014-07-01
PublicationDate_xml – month: 07
  year: 2014
  text: July 2014
PublicationDecade 2010
PublicationTitle European journal of cancer (1990)
PublicationYear 2014
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
SSID ssj0007840
Score 2.1582308
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage S195
SubjectTerms Hematology, Oncology and Palliative Medicine
Title 808: The PI3K/mTOR inhibitor NVP-BEZ235 is able to revert selumetinib resistance in colorectal cancer cellular models
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0959804914507137
https://dx.doi.org/10.1016/S0959-8049(14)50713-7
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED6VIiEWxFOUlzwwwOA2zssJW0GgAqIgKAixWPEjIgMBNenKb-ecpAUEYmDMSeckn-27z_bdGWAfKbtirjE01YFHfe1qmmiV0NRWN5dKq6C6veFqGA7u_YvH4LEFJ9NcGBtW2dj-2qZX1rqR9Bo0e29Z1ruzO1gRElzmW07j8TmYrw6J2jDfP78cDGcGmUdVXmS944UKn4k8dSOV8ID5h1U7lP_uor64nbNlWGr4IunXn7QCLZOvwsJVcyK-BpPIiY4Idja5Ofcuey-j61uS5c-ZxJk6JsOHG3p8-uR6AckKYrOkSPlKbNWmcUkKYw1TmeWZRFFhiST-PWoTW8naooIvVlY2JnZ_3waskurmnGId7s9ORycD2lylQBULOKcyZim6Q0_J1FFBrGxhL2Z8E0p0-NoLJS6EAx3hc5gk3DFRHEqJVA_JR5pyRGUD2vlrbjaBWEYQJk7CmPT8ULNYu2GcYOuuY3BtKTvQnaIn3uqKGeIzlAzhFhZuXHKICm7BO8CnGItpOigaMFM0s6kQTBSucMSPHu9ANNP8NmgE-oO_X7r1f9VtWETW5NcxuzvQLscTs4vMpJR7MNd9Z3vN-PsA0ejcLg
link.rule.ids 315,783,787,4511,24130,27938,27939,45599,45693
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkCgXVGhRFyj4wAEOZuO8nHCjCLQ8dkF0qRAXK35EzYGANuHKb2cmyXaLijhwzCi248_2zGdnZgywg5TdCN85ntso4KH1Lc-syXhO2c21sSZqbm8YjuLBTXh2G93OwdE0FobcKjvd3-r0Rlt3kn6HZv-xKPq_6AQrQYIrQuI0gfwECyHlz8JJvf888_OQSRMV2Z534euzMJ62ika4K8K9phYu3zZQ_xidky-w3LFFdth-0ArMuXIVFofd__Cv8JR4yQHDoWZXp8F5_358ec2K8k-hcZ1O2Oj3Ff95fOcHESsqRjFSrH5glLNpUrPKkVqqi7LQKKqIRmLfsTSjPNaECTZsSDZhdLpP7qqsuTen-gY3J8fjowHvLlLgRkRScp2KHI1hYHTumSg1lNZLuNDFGs29DWKN2-DIJvgcZ5n0XJLGWiPRQ-qR5xJRWYP58qF034ERH4gzLxNCB2FsRWr9OM2wdt9zuLPUPdifoqce23wZauZIhnArghs3HKqBW8keyCnGahoMiurLVd1aqpRQla889d949yD5W_LVlFFoDd5vdP3jRbfh82A8vFAXp6PzDVhC_hS23rubMF9PntwP5Ci13mrm4AvZqt0Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=808%3A+The+PI3K%2FmTOR+inhibitor+NVP-BEZ235+is+able+to+revert+selumetinib+resistance+in+colorectal+cancer+cellular+models&rft.jtitle=European+journal+of+cancer+%281990%29&rft.au=Martinez-Lacaci%2C+I&rft.au=Carballo-Santana%2C+M&rft.au=Tristante%2C+E&rft.au=Mayor-L%C3%B3pez%2C+L&rft.date=2014-07-01&rft.issn=0959-8049&rft.volume=50&rft.spage=S195&rft.epage=S195&rft_id=info:doi/10.1016%2FS0959-8049%2814%2950713-7&rft.externalDBID=ECK1-s2.0-S0959804914507137&rft.externalDocID=1_s2_0_S0959804914507137
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09598049%2FS0959804914X00146%2Fcov150h.gif